Abvc Biopharma Inc Reports Results For The Quarter Ended In September: Earnings Summary

ABVC Biopharma

15/11/2022 24:39

* ABVC Biopharma Inc  ABVC.OQ  reported a quarterly adjusted
loss
of 11 cents​​ per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was for a loss
of 12 cents per share.
    * Revenue fell 57.6% to $42.00 thousand from a year ago;
analysts
expected $13.00 thousand. 
    * ABVC Biopharma Inc's reported EPS for the quarter was a
loss
of 11 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * ABVC Biopharma Inc shares had fallen by 18.0% this
quarter and
lost 78.7% so far this year.
    * The company reported a quarterly loss of $3.71 million.
    * Wall Street's median 12-month price target for ABVC
Biopharma
Inc is $3.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
15 at 12:39 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.12          -0.11          Beat
 Jun. 30 2022      -0.12          -0.06          Beat
                                  -0.20          
 Dec. 31 2021      -0.04          -0.31          Missed